Keywords
Wilson's disease, liver disease, basic liver function tests, Nepal
Wilson's disease, liver disease, basic liver function tests, Nepal
Wilson’s disease is an autosomal recessive disorder of copper metabolism that leads to liver disease and neuropsychiatric manifestations. The majority of patients are diagnosed between the ages of five and 35 years. This disease is usually suspected in patients with liver disease of uncertain etiology, especially if accompanied by neuropsychiatric symptoms. But it can also present with liver abnormalities alone. Untreated, this disease is universally fatal, with patients dying from cirrhosis or progressive neurologic disease.1 Hence its timely recognition is important. It is not usually diagnosed in resource-limited countries as diagnostic tests are not easily available. Here we present a case of Wilson’s disease from Nepal. The patient presented with liver disease (without neuropsychiatric features), and we discuss how basic liver function test parameters can be used as a guide to suspected Wilson’s disease.
A 36-year-old woman from Lalitpur, Nepal presented to the emergency department of Patan Hospital in December 2018, with complaints of abdominal distension and yellowish discoloration of the skin for two months and shortness of breath for the last 10 days. She had no history of fever, cough, abdominal pain, nausea, vomiting, black stools, altered sensorium or abnormal body movement. She had a history of consuming home-made alcohol, almost daily for 12 years, although quantification of the intake could not be done.
On examination she appeared icteric and pale. Blood pressure was 90/60 mm Hg, pulse 78 beats per minute, respiratory rate 20 breaths per minute, temperature 98.7 Fahrenheit and oxygen saturation of 97% at room temperature. Abdomen was distended and non-tender, liver and spleen were not palpable and shifting dullness was present. Chest examination showed decreased air entry. Bilateral pitting pedal edema was noted. Neurological examinations did not reveal any abnormality. She was looked after at another health care center three weeks prior to her admission as a case of alcoholic liver disease. She stopped drinking alcohol, but without improvement in her symptoms. Her investigations are as shown in Table 1.
Ultrasound of the abdomen showed hepatosplenomegaly and gross ascites. Ascitic fluid tap was done and sent for analysis, which showed WCC 100 cells/μL (neutrophils 60% and lymphocytes 40%), protein 1 gm/dl and albumin 0.5 gm/dl. Upper gastrointestinal endoscopy showed small sized esophageal varices and mild portal hypertensive gastropathy. Hepatitis B surface antigen (HBsAg) and hepatitis C antibody were nonreactive. Direct Coombs test was negative. Patient was started on furosemide 20 mg once daily, spironolactone 50 mg once daily and thiamine 100 mg once daily.
Slit lamp examination of her eyes showed the presence of Kayser–Fleischer (KF) rings. Twenty-four-hour urinary copper was 85.70 (normal < 60) μg and serum ceruloplasmin level was 23 (normal 20–60) mg/dl. The diagnosis of subacute liver failure with Wilson’s disease was made. We started oral zinc acetate (50 mg elemental zinc thrice daily) along with the above drugs and she was discharged in one week of admission. There was clinical and biochemical improvement as seen during one-month (January 2019) and 11 months (November 2019) follow-up visits (Table 1).
This female patient who presented with features of chronic liver disease had a history of alcohol intake for almost 12 years. Nepal is a low-income country in South Asia, and a full chronic liver disease screening (including tests for Wilson’s disease, autoimmune hepatitis, hemochromatosis) is usually not possible in the Nepali health setup. The limited screen includes alcohol history, history of any drug or toxin use and serologies for hepatitis B and C.2 However, the people mostly consume home-made alcohol in Nepal, and the exact quantification is usually not possible to estimate whether the amount of intake is significant enough to cause liver disease or not.3 We usually ascribe liver disease in any patient to the alcohol, no matter the amount of intake by the patient, especially if serologies are nonreactive and there is no drug or toxin exposure. In our patient with a history of alcohol use, we extended the tests beyond the conventional limited screen, which led to a diagnosis of Wilson’s disease.
Basic liver function tests (LFT) including bilirubin, transaminases level and alkaline phosphatase (ALP) are available in most of the health centers in Nepal. In any patient with liver disease who presents with acute liver failure, the combined ratio of ALP/total bilirubin (<4) and aspartate transaminase (AST)/alanine transaminase (ALT) (>2.2) provides sensitivity and specificity of 100% for diagnosing Wilson’s disease.4 In our patient, ALP/total bilirubin was 3.09 and AST/ALT was 3.4 during the admission (Table 2). Although she did not have acute liver failure during the presentation, we used this pattern of LFT (the ‘Wilson’s pattern’) as a guide to suspect the possibility of Wilson’s disease and ordered slit lamp examination of eyes for KF rings, serum ceruloplasmin level and 24-hour urinary copper tests.
(alkaline phosphatase (ALP), aspartate transaminase (AST), alanine transaminase (ALT)).
ALP/total bilirubin | AST/ALT | |
---|---|---|
Three weeks prior to admission (November 2018) | 2.43 | 3.6 |
Day of admission (December 2018) | 3.09 | 3.4 |
One month later (January 2019) | 16.9 | 1.4 |
11 months later (November 2019) | 62.5 | 1.5 |
The diagnosis was made using the Leipzig scoring system for Wilson’s disease.5 Total points obtained were four (two for KF ring, one for Coombs negative hemolytic anemia, one for high 24-hour urinary copper), which established the diagnosis of Wilson’s disease. However, she had no neurologic symptoms and her serum ceruloplasmin level was normal. Liver copper and mutation analysis were not performed.
Treatment with zinc acetate was started in this case because of unavailability of chelating agents. On follow up in one month, she had no abdominal distension and jaundice. LFTs were improved, which continued to improve till 11 months follow up (Table 1). Even the ‘Wilson’s pattern’ of LFTs was resolved with treatment (Table 2).
LFTs are simple and readily available tests even in remote parts of Nepal, done in all patients with liver disease. As screening for rare diseases is not always possible in low-income countries, this case demonstrates the usefulness of the ‘Wilson’s pattern’ LFT as a guide for suspecting Wilson’s disease in patients with liver disease. However, the sensitivity and specificity of this pattern is yet to be studied in patients with subacute liver disease.
All data underlying the results are available as part of the article and no additional source data are required.
Written informed consent for publication of the clinical details and/or clinical images was obtained from the patient.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the background of the case’s history and progression described in sufficient detail?
Yes
Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?
Yes
Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?
Partly
Is the case presented with sufficient detail to be useful for other practitioners?
Partly
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Expertise in basic biology of Wilson Disease and working knowledge of diagnostic procedures.
Is the background of the case’s history and progression described in sufficient detail?
Partly
Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?
Partly
Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?
Partly
Is the case presented with sufficient detail to be useful for other practitioners?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Liver disease, Wilson' disease, pediatric liver disease
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 2 (revision) 03 Mar 22 |
read | |
Version 1 20 Jul 21 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)